Drug name - Trudhesa

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9550036 IMPEL NEUROPHARMA Nasal drug delivery device Sep, 2032

(9 years from now)

US10507295 IMPEL NEUROPHARMA Nasal drug delivery device Dec, 2032

(10 years from now)

US10940278 IMPEL NEUROPHARMA Nozzles for nasal drug delivery Jan, 2033

(10 years from now)

US9919117 IMPEL NEUROPHARMA Nozzles for nasal drug delivery Mar, 2033

(10 years from now)

US11185497 IMPEL NEUROPHARMA Intranasal delivery of dihydroergotamine by precision olfactory device Jan, 2039

(16 years from now)

Drugs and Companies using DIHYDROERGOTAMINE MESYLATE ingredient

Treatment: Nasal administration of dihydroergotamine mesylate by metered spray for the acute treatment of migraine with or without aura

Dosage: SPRAY, METERED;NASAL

More Information on Dosage
Strength Dosage Availability
0.725MG/SPRAY SPRAY, METERED;NASAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.